Published in Transplantation on March 15, 2006
Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50
HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol (2010) 1.89
Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol (2009) 1.69
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50
Emerging role of autophagy in kidney function, diseases and aging. Autophagy (2012) 1.43
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology (2010) 1.39
MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant (2011) 1.27
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics (2009) 1.18
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact. Nat Rev Drug Discov (2010) 1.08
Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One (2009) 1.03
MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation (2012) 1.03
Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med (2008) 0.94
Every allograft needs a silver lining. J Clin Invest (2007) 0.91
HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients. J Am Soc Nephrol (2015) 0.90
Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med (2007) 0.88
Histone deacetylase inhibitors and transplantation. Curr Opin Immunol (2007) 0.87
Metabolic stress promotes renal tubular inflammation by triggering the unfolded protein response. Cell Death Dis (2011) 0.87
Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy. Nephrol Dial Transplant (2008) 0.86
Proteomics and metabolomics in renal transplantation-quo vadis? Transpl Int (2012) 0.85
Type I interferon pathway mediates renal ischemia/reperfusion injury. Transplantation (2011) 0.85
Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol (2011) 0.82
The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33. PLoS One (2014) 0.82
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res (2012) 0.81
Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat. PLoS One (2012) 0.81
Evaluation of vascular lesions using circulating endothelial cells in renal transplant patients. Clin Transplant (2012) 0.80
"Nature versus nurture" study of deceased-donor pairs in kidney transplantation. J Am Soc Nephrol (2009) 0.80
Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions. Expert Opin Drug Metab Toxicol (2011) 0.80
Analysis of machine perfusion benefits in kidney grafts: a preclinical study. J Transl Med (2011) 0.79
Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism. J Proteome Res (2012) 0.79
Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol (2011) 0.78
Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy. J Mol Diagn (2010) 0.78
What's past is prologue: developmental pathways and chronic allograft dysfunction. Am J Transplant (2011) 0.78
Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation. Clin Exp Pharmacol Physiol (2007) 0.78
Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways. Pediatr Nephrol (2008) 0.78
Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection. BMC Nephrol (2015) 0.78
The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury. Transplantation (2016) 0.77
Chronic allograft nephropathy in paediatric renal transplantation. Pediatr Nephrol (2006) 0.77
Outcomes after pediatric kidney transplantation improving: how can we do even better? Pediatrics (2014) 0.77
Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury. BMC Genomics (2013) 0.77
Kidney transplantation in patients with systemic lupus erythematosus. World J Transplant (2014) 0.77
Monocytic Tissue Transglutaminase in a Rat Model for Reversible Acute Rejection and Chronic Renal Allograft Injury. Mediators Inflamm (2015) 0.77
Lymphoid-Like Structures with Distinct B Cell Areas in Kidney Allografts are not Predictive for Graft Rejection. A Non-human Primate Study. Inflammation (2015) 0.76
Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation. PLoS One (2016) 0.76
N-Octanoyl dopamine transiently inhibits T cell proliferation via G1 cell-cycle arrest and inhibition of redox-dependent transcription factors. J Leukoc Biol (2014) 0.75
Clinical aspects: focusing on key unique organ-specific issues of renal transplantation. Cold Spring Harb Perspect Med (2014) 0.75
High-Throughput Proteomic Approaches to the Elucidation of Potential Biomarkers of Chronic Allograft Injury (CAI). Proteomes (2013) 0.75
Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction. Nephrol Dial Transplant (2012) 0.75
Expression of acetylcholine receptors by experimental rat renal allografts. Biomed Res Int (2014) 0.75
Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients. Antimicrob Agents Chemother (2013) 0.75
Clinical Course and Outcomes of Late Kidney Allograft Dysfunction. J Transplant (2016) 0.75
Metabolomic Profiling in Individuals with a Failing Kidney Allograft. PLoS One (2017) 0.75
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40
How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82
The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78
Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58
Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57
Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53
Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation (2012) 1.50
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48
The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation (2014) 1.44
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation (2015) 1.40
Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis (2008) 1.39
Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. Transplantation (2014) 1.39
Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transpl Int (2008) 1.37
Cancer after renal transplantation: the next challenge. Am J Transplant (2004) 1.23
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23
Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation (2004) 1.20
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev (2010) 1.15
Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol (2008) 1.06
Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. Transplantation (2013) 1.05
Belatacept for kidney transplant recipients. Cochrane Database Syst Rev (2014) 0.99
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance. Nephrol Dial Transplant (2007) 0.99
Delta analysis of posttransplantation tubulointerstitial damage. Transplantation (2004) 0.96
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant (2006) 0.95
Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol (2008) 0.93
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. Transplantation (2016) 0.92
Cancers after renal transplantation. Transplant Rev (Orlando) (2008) 0.92
No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer (2010) 0.92
Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation (2004) 0.91
Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation (2006) 0.89
Sirolimus: its role in nephrology. Nephrology (Carlton) (2005) 0.88
Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation (2008) 0.88
Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. Med J Aust (2006) 0.87
The expectations and attitudes of patients with chronic kidney disease toward living kidney donor transplantation: a thematic synthesis of qualitative studies. Transplantation (2015) 0.87
Transcriptome changes of chronic tubulointerstitial damage in early kidney transplantation. Transplantation (2010) 0.87
Exercise training in solid organ transplant recipients: a systematic review and meta-analysis. Transplantation (2013) 0.86
Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology (Carlton) (2010) 0.86
Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation (2006) 0.86
Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients. Transplantation (2015) 0.86
Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation (2004) 0.84
Increased incidence of squamous cell carcinoma of eye after kidney transplantation. J Natl Cancer Inst (2007) 0.84
Clinical Utility of Urinary Cytology to Detect BK Viral Nephropathy. Transplantation (2015) 0.84
Individualization of immunosuppression: concepts and rationale. Curr Opin Organ Transplant (2008) 0.83
Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial. Transplantation (2012) 0.83
Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection. Transplantation (2004) 0.83
Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transplant (2010) 0.83
World Kidney Day 2012: the global role of kidney transplantation. Am J Kidney Dis (2012) 0.83
What are the key challenges we face in kidney transplantation today? Transplant Res (2013) 0.82
Reported cancer screening practices of nephrologists: results from a national survey. Nephrol Dial Transplant (2009) 0.82
Organ donation: a chance for Australia to do better. Med J Aust (2006) 0.82
Chronic allograft nephropathy--a clinical syndrome: early detection and the potential role of proliferation signal inhibitors. Clin Transplant (2009) 0.82
Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis. Transplantation (2016) 0.81
Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer. Nephrology (Carlton) (2012) 0.81
The global role of kidney transplantation. Kidney Int (2012) 0.81
Public awareness and attitudes to living organ donation: systematic review and integrative synthesis. Transplantation (2013) 0.81
Genetic and functional evaluation of the level of inbreeding of the Westran pig: a herd with potential for use in xenotransplantation. Xenotransplantation (2005) 0.80
The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation (2012) 0.80
Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer. Transplantation (2015) 0.79
The experiences of commercial kidney donors: thematic synthesis of qualitative research. Transpl Int (2012) 0.79
The risk of cancer in people with diabetes and chronic kidney disease. Nephrol Dial Transplant (2012) 0.79
Detection of chronic allograft nephropathy by quantitative doppler imaging. Transplantation (2002) 0.79
Economic evaluations in kidney transplantation: frequency, characteristics, and quality-a systematic review. Transplantation (2014) 0.78
Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies. Nephrol Dial Transplant (2008) 0.78
Public attitudes and beliefs about living kidney donation: focus group study. Transplantation (2014) 0.78
Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health (2011) 0.78
The preferences and perspectives of nephrologists on patients' access to kidney transplantation: a systematic review. Transplantation (2014) 0.78
Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. Biol Blood Marrow Transplant (2013) 0.78
Why do patients develop proteinuria with sirolimus? Do we have the answer? Am J Kidney Dis (2010) 0.77
Association between delayed graft function and graft loss in donation after cardiac death kidney transplants - a paired kidney registry analysis. Transplantation (2016) 0.77
The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation (2009) 0.77
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation (2017) 0.76
Tolerance induction in a large-animal model using total lymphoid irradiation and intrathymic bone marrow. Transplantation (2008) 0.76
Excellent outcomes of simultaneous pancreas kidney transplantation in patients from rural and urban Australia: a national service experience. Transplantation (2012) 0.76
Nephrologists' Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation. Transplantation (2016) 0.76
Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients. Transplantation (2012) 0.75
Transplantation: the global role of kidney transplantation. Nat Rev Nephrol (2012) 0.75
Debate on financial incentives is off the mark of national and international realities. Transplantation (2010) 0.75
Can the risk of skin cancer after transplantation be reduced by mTOR Inhibitors? Am J Kidney Dis (2013) 0.75
Transplantation Reaches 100th Volume. Transplantation (2016) 0.75
The global role of kidney transplantation. Am J Hypertens (2012) 0.75
The Impact of Total Ischemic Time, Donor Age and the Pathway of Donor Death on Graft Outcomes After Deceased Donor Kidney Transplantation. Transplantation (2017) 0.75
Message From the Editor. Transplantation (2016) 0.75
Care of Transplant Recipients in Primary Practice. Transplantation (2016) 0.75
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane Database Syst Rev (2017) 0.75
Expectations and experiences of follow up and self-care after living kidney donation: a focus group study. Transplantation (2017) 0.75
The Global Alliance for Transplantation. Transplantation (2005) 0.75
Unravelling the connections between donor specific antibodies and renal allograft pathology. Clin Transpl (2013) 0.75
Association Between Delayed Graft Function and Graft Loss in Donation After Cardiac Death Kidney Transplants-A Paired Kidney Registry Analysis. Transplantation (2017) 0.75